FDA panel to evaluate psychedelic MDMA for treatment of PTSD for first time
Fox News
The U.S. Food and Drug Administration held a meeting to discuss a therapy based on the psychedelic drug MDMA for patients with post-traumatic stress disorder for the first time.
It follows a decades-long push by advocates who say drugs like MDMA can treat mental health disorders and have therapeutic applications beyond their illicit use.
More Related News
Clonazepam, popular anxiety-reducing drug, recalled nationwide for ‘possibly life-threatening’ error
The anxiety-reducing drug, Clonazepam, has been recalled after a potentially "life-threatening" label mix-up, the FDA said in the recall.